Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF May 11, 2012 Issue | Archived Issues

New FDA alerts

Pharmacy focus

The U.S. Food and Drug Administration issued updates and warnings for phenytoin, fosphenytoin, dronedarone, aliskiren and other drugs.

» Read more


Physician news

David Rimoin, MD, PhD, named an American College of Physicians master, Ilana Cass, MD, selected for the Executive Leadership in Academic Medicine fellowship, a Kawasaki disease study by Moshe Arditi, MD, honored at conference, and Robert H. Baloh, MD, PhD, received ALS Association award.

» Read more


Meetings and events


Grand rounds

Click here to view upcoming Grand Rounds.


Upcoming CME conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - May 2012 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Physician news

Arditi's Kawasaki disease study wins award

Moshe Arditi, MD, director of the Cedars-Sinai Division of Pediatric Infectious Diseases, recently presented a study on Kawasaki disease, a leading cause of acquired heart disease in children, at a conference in Kyoto, Japan. There, he and his research were honored by Tomisaku Kawasaki, the Japanese pediatrician who first described the illness in 1967.

The study, which won the Best Basic Science Study Award at the 10th International Kawasaki Disease Symposium, is titled "IL-1β is Crucial for Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease." It was conducted by Young Ho Lee, PhD, a post-doctoral researcher in Arditi's lab.

Recently published in the journal Circulation, Arditi’s study stimulated the design of a new clinical trial to test the use of anti-İL1 beta monoclonal antibody in children with Kawasaki disease who do not respond to the current treatment of intravenous Gamma Globulin (IVIG) to prevent coronary artery lesions. The syndrome primarily affects young children, and, if untreated, can lead to coronary lesions in 25 percent of patients.


Baloh receives ALS Association award

Robert H. Baloh, MD, PhD, director of the Neuromuscular Division in Cedars-Sinai's Department of Neurology, has received the ALS Association Golden West Chapter Commitment to a Cure Award.

Baloh, an expert in research and treatment of amyotrophic lateral sclerosis, has published groundbreaking discoveries in genetics and molecular biology and is the principal investigator of five projects examining the molecular and cellular basis of ALS and other neuromuscular disorders.


Cass selected for Executive Leadership in Academic Medicine fellowship

Ilana Cass, MD, was selected as a fellow for the 2012-13 Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women at Drexel University College of Medicine in Philadelphia.

The program is the only one of its kind in the U.S. dedicated to preparing senior women faculty for positions of leadership at academic health centers, according to Drexel.

Cass, vice chair of the Department of Obstetrics and Gynecology, is the first woman from Cedars-Sinai accepted to this program, said Sarah J. Kilpatrick, MD, PhD, chair of the Ob-Gyn Department.


Rimoin named American College of Physicians master

David Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute and Steven Spielberg Family Chair in Pediatrics, was awarded a mastership by the American College of Physicians, the highest honor given by the nation’s largest medical-specialty organization.

The Masters of the American College of Physicians are accomplished physicians determined to have achieved excellence in practice or medical research, positions of honor and contributions toward furthering the mission of the organization. Only a handful of the college’s 132,000 members are awarded this designation.

Rimoin was nominated by fellow ACP Master Glenn D. Braunstein, MD, vice president for Clinical Innovation, director of the Cedars-Sinai Thyroid Cancer Center and James R. Klinenberg, MD, Chair in Medicine. Braunstein said Rimoin warranted recognition for his contributions to the field of medical genetics.

Rimoin has served as the founding president of the American Board of Medical Genetics and the American College of Medical Genetics, as well as the president of the American Society of Human Genetics, the Western Society for Pediatric Research and the Western Society for Clinical Research.  He also is director of the International Skeletal Dysplasia Registry, the largest such registry in the world.